Search Results 241-250 of 12357 for Multiple myeloma red flag

1. Bortezomib (intravenous route, subcutaneous route) - Side effects & uses - Mayo Clinic

   Bortezomib injection is used to treat multiple myeloma ... This medicine may cause some people to become dizzy, drowsy, tired, or less alert than they are ...

2. Lenalidomide Or Observation In Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma - Mayo Clinic

   ... multiple myeloma. Biological therapies such as lenalidomide, may stimulate the immune system in different ways and stop cancer cells from growing. Sometimes ...

3. A Study To Determine Recommended Dose, Regimen And Evaluate The Safety And Preliminary Effectiveness Of CC-92480 In Combination With Standard Treatments In Subjects With Relapsed Or Refractory Multiple Myeloma (RRMM) And Newly Diagnosed Multiple Myeloma (NDMM) - Mayo Clinic

   ... Multiple Myeloma (RRMM) And Newly Diagnosed Multiple Myeloma (NDMM). Print details. Share; Facebook · Twitter. Overview; Participation eligibility ...

4. Safety and Efficacy of ALLO-605 an Anti-BCMA Allogeneic CAR T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma - Mayo Clinic

   Safety and Efficacy of ALLO-605 an Anti-BCMA Allogeneic CAR T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma · Overview · Participation ...

5. CAR-T cell therapy - Mayo Clinic

   It's most often used to treat cancers that affect blood cells, such as certain types of leukemia, lymphoma and multiple myeloma. CAR-T cell therapy stands ...

6. Safety And Efficacy Of ALLO-715 And ALLO-647 BCMA Allogenic CAR T Cells In In Adults With Relapsed Or Refractory Multiple Myeloma (UNIVERSAL) - Mayo Clinic

   Safety And Efficacy Of ALLO-715 And ALLO-647 BCMA Allogenic CAR T Cells In In Adults With Relapsed Or Refractory Multiple Myeloma (UNIVERSAL) · Share · Facebook ...

7. Cyclophosphamide, Carfilzomib, Thalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed Active Multiple Myeloma - Mayo Clinic

   Cyclophosphamide, Carfilzomib, Thalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed Active Multiple Myeloma ... multiple myeloma.

8. A Study To Evaluate ION251 To Treat Patients With Relapsed/Refractory Multiple Myleoma - Mayo Clinic

   ... multiple myeloma. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health ...

9. Innovative Multiple Myeloma Care Renews a Pilot's Energy and Outlook - Mayo Clinic News Network

   But nothing prepared Harold for a diagnosis in early 2009 of multiple myeloma, a cancer of the plasma cells inside bone marrow, which is considered incurable. “ ...

10. Hematology - Clinical trials

    ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step-up dose optimization (Part ...